ISSN 2407-2230 | E-ISSN 1907-3062 | Universa Medicina content is searchable on DOAJ, Google Scholar, and OAI

Hormonal contraception increases risk of breast tumor based on clinical breast examination among adult women

Sulistyowati Tuminah Darjoko, Aprildah Nur Sapardin
Submission date: Friday, 26 May 2017
Published date: Monday, 14 August 2017


In Indonesia, cancer prevalence according to the Basic Health Research 2013 was 1.4 per 1000 inhabitants and the most common cancer in hospitalized patients in 2010 was breast cancer (28.7%). Hormonal contraception (HC) use increases the breast cancer risk, even though HC has been used by 210 million women in the world. We aimed to define the association of HC with breast tumors based on clinical breast examination (CBE).

A case-control design using secondary data from the baseline of the Cohort Study on the Risk Factors of Non-Communicable Disease (RFNCD) in 2011-2012 in 5 villages in Central Bogor District, Bogor City. Samples consisted of 152 cases and 152 controls. Cases comprised palpable tumors in one or both breasts CBE (+). Controls had no tumors in both breasts /CBE(-). Data were analyzed by logistic regression.

Odds Ratio (OR) of CBE + was 1.83 (95% CI: 1.11-3.04; p=0.019) for HC user and 1.62 (95% CI: 1.01-2.60; p=0.044) for blood total cholesterol level <200 mg/dL. OR of group CBE(+) was 1.01 (current smoking) and 0.49 (former smoking) compared with nonsmoking (p=0.082); OR was also 1.21 for subjects with one child and 1.77 for those without children, compared with those who had ³2 children (p=0.454).

Hormonal contraception use increases breast tumor risk 1.8-fold after controlling for total cholesterol, smoking status and parity. With the several limitations of this advanced analysis, investigations focused on types and duration of HC use are still necessary.


Hormonal contraceptionl breast tumor; adult women

Full Text:



Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90. Doi: 10.3322/caac.20107.

International Agency for Research on Cancer World Health Organization. Global cancer burden rises to 14.1 million new cases in 2012: marked increase in breast cancers must be addressed. Lyon, France: International Agency for Research on Cancer;2013.

Wahidin M. Deteksi dini kanker leher rahim dan kanker payudara di Indonesia 2007-2014. Buletin Jendela Data Informasi 2015;Semester I:12-5.

Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 2014;144:1-10. Doi: 10.1007/s10549-014-2852-7.

Zahra Z, Khairun N. Analisis hubungan penggunaan kontrasepsi hormonal dengan disfungsi seksual pada wanita. Majority 2015;4: 103-8.

Sety LM. Jenis pemakaian kontrasepsi hormonal dan gangguan menstruasi di wilayah kerja Puskesmas. J Kesehatan 2014;5:60-6.

Yue W, Wang JP, Li Y, et al. Effects of estrogen on breast cancer development: role of estrogen receptor independent mechanisms. Int J Cancer 2010;127:1748-57. Doi: 10.1002/ijc.25207.

Daniel AR, Hagan CR, Lange CA. Progesterone receptor action: defining a role in breast cancer. Expert Rev Endocrinol Metab 2011;6:359-69. Doi:10.1586/eem.11.25.

Urban M, Banks E, Egger S, et al. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in Black South African Women: case-control study. PLoS Med 2012;9:e1001182. Doi: 10.1371/journal.p med.1001182.

Sihombing M, Sapardin AN. Faktor risiko tumor payudara pada perempuan umur 25-65 tahun di lima Kelurahan di Kecamatan Bogor Tengah. J Kesehatan Reproduksi 2014;5:175-84.

Sirait AM, Ratih O, Lely I. Hubungan kontrasepsi pil dengan tumor/kanker payudara di Indonesia. Maj Kedokt Indon 2009;59:348-56.

Zafar A. Clinical breast examination: the diagnostic accuracy in palpable breast lumps. Prof Med J 2014;21:1147-52.

Ravi C, Rodriguez G. Accuracy of clinical examination of breast lumps in detecting malignancy: retrospective study. Indian J Surg Oncol 2012;3:154-7. Doi: 10.1007/s13193-012-0151-5.

Khoda L, Kapa B, Singh KG, et al. Evaluation of modified triple test (clinical breast examination, ultrasonography, and fine-needle aspiration cytology) in the diagnosis of palpable breast lumps. J Med Soc 2015;29:26-30.

Poosari A, Promthet S, Kamsaard S, Suwanrungruang K, Longkul J, Wiangnon S. Hormonal contraceptive use and breast cancer in Thai women. J Epidemiol 2014;24:216-20. Doi: 10.2188/jea.JE20130121.

Sastroasmoro S, Ismael S. Dasar-dasar metodologi penelitian klinis. Edisi ke-5. CV. Sagung Seto Jakarta. 2014.

Badan Penelitian dan Pengembangan Kesehatan. Laporan studi kohor faktor risiko penyakit tidak menular (PTM). Jakarta;2012.

Xue F, Willett WC, Rosner BA, et al. Cigarette smoking and the incidence of breast cancer. Arch Intern Med 2011;171125-33. Doi: 10.1001/archinternmed.2010.503.

Scholte WF, Verduin F, van Lammeren A, et al. Psychometric properties and longitudinal validation of the self-reporting questionnaire (SRQ-20) in a Rwandan community setting: a validation study. BMC Med Res Method 2011;11:116. Doi: 10.1186/1471-2288-11-116.

Sun X, Nichols HB, Tse CK, et al. Association of parity and time since last birth with breast cancer prognosis by intrinsic subtype. Epidemiol Biomarkers Prev 2015;251:60-7. Doi: 10.1158/1055-9965.EPI-15-0864.

Ambrosone CB, Zirpoli G, Ruszczyk M, et al. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women’s Circle of Health Study. Cancer Causes Control 2014;25:259-65. Doi: 10.1007/s10552-013-0323-9.

Sulistyowati T, Sihombing M. Frequent coconut milk intake increases the risk of vascular disease in adults. Univ Med 2015;34: 149-58. Doi: 10.18051/Univmed.2015.v34.149-158.

Gray LJ, Yates T, Davies MJ, et al. Defining obesity cut-off points for migrant South Asians. PLoS ONE 2011;6: e26464. Doi: 10.1371/journal.pone.0026464.

Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. Nutrients 2013;5:2708-33. Doi: 10.3390/nu5072708.

Jacobson TA, Ito MK, Maki KC, et al. National lipid association recommendation for patient-centered management of dyslipidemia: Part 1-Full Report. Journal J Clin Lipidol 2015;9:129-69. doi: 10.1016/j.jacl.2015.02.003.

Hastono SP. Analisis data. Jakarta: FKM UI; 2006.

Artoum M, Al Hourani H, Nimer N, et al. Endogenous estradiol, estrogen and progesterone receptors increase benign and breast cancer risk among non-familial postmenopausal females. Health Sci J 2012;6:693-702.

Palmer JR, Viscidi E, Troester MA, et al. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER consortium. J Natl Cancer Inst 2014;106:1-8. Doi: 10.1093/jnci/dju237.

Chen WY. Exogenous and endogenous hormones and breast cancer. Best Pract Res Clin Endocrinol Metab 2008;22:573-85. Doi: 10.1016/j.beem. 2008.08.001.

Lanari C, Wargon V, Rojas P, et al. Antiprogestins in breast cancer treatment: are we ready? Endocr Relat Cancer 2012;19:R35-50. doi: 10.1530/ERC-11-0378.

Llanos AA, Makambi KH, Tucker CA, et al. Cholesterol, lipoprotein, and breast cancer risk in African American women. Ethn Dis 2012; 22:281-7.

Shah FD, Shukla SN, Shah PM, et al. Significance of alterations in plasma lipid profiles levels in breast cancer. Intregr Cancer Ther 2008;7:33-41.

Melvin JC, Seth D, Holmberg L, et al. Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS Study. Cancer Epidemiol Biomarkers Prev 2012;21:1381-4. Doi: 10.1158/1055-9965.

Ni H, Liu H, Gao R. Serum lipids and breast cancer risk: a meta-analysis of prospective cohort studies. PloS ONE 2015;10:1-15. e0142669. Doi: 10.1371/journal.pone.0142669.

Kitahara CM, de González AB, Freedman ND, et al. Total cholesterol and cancer risk in large prospective study in Korea. J Clin Oncol 2011;29:1592-8. Doi: 10.1200/JCO.2010.31. 5200.

Hu J, La Vecchia C, de Groh M, et al. Dietary cholesterol intake and cancer. Ann Oncol 2012;23:491-500. Doi: 10.1093/annonc/mdr 155.

Peela JR, Jarari AM, El Saiety SO, et al. The relationship between serum lipids and breast cancer in Libya. Biochem Anal Biochem 2012;1: 1-3. Doi: 10.4172/2161-1009.1000117.

Llaverias G, Danilo C, Mercier I, et al. Role of cholesterol in the development and progression of breast cancer. Am J Pathol 2011;178:402-12. Doi: 10.1016/j.ajpath.2010.11.005.

McDonell D, Chang CY, Nelson ER. The estrogen receptor as a mediator of the pathological action of cholesterol in breast cancer. Climacteric 2014;17:60-5. Doi: 10.3109/13697137.2014.966949

Kumar V, Singh A, Sidhu DS, et al. A comparative study to evaluate the role of serum lipid levels in aetiology of carcinoma breast. J Clin Diag Res 2015;9:PC01-PC3. Doi: 10.7860/JCDR/2015/12273.5563.

Hu J, Zhang Z, Shen WJ, et al. Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutri Metab 2010;7:47. doi: 10.1186/1743-7075 -7-47.

Pasarelli MN, Newcomb PA, Hampton JM, et al. Cigarette smoking before and after breast cancer diagnosis: Mortality from breast cancer and smoking-related diseases. J Clin Oncol 2016;34:1315-22. Doi: 10.1200/JCO.2015.63. 9328.

Bjerkaas E, Parajuli R, Engeland A, et al. The association between lifetime smoking exposure and breast cancer mortality – results from a Norwegian cohort. Cancer Med 2014:1-10. Doi: 10.1002/cam4.304.

Bishop JD, Killelea BK, Chagpar AB, et al. Smoking and breast cancer recurrence after breast conservation therapy. Int J Breast Cancer 2014, Article ID 327081, 5 pages. http://dx.doi. org/10.1155/2014/327081

Shen S, Zhong S, Xiao G, et al. Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis. Onco Targets Ther 2017;10:477-81.

Heys M, Jiang C, Cheng KK, et al. Life long endogenous estrogen exposure and later adulthood cognitive function in a population of naturally postmenopausal women from Southern China: the Guangzhou Biobank cohort study. Psychoneuroendocrinology 2011;36:864-73. Doi: 10.1016/j.psyneuen.2010.11.009.

Xue J, Yang S, Seng S. Mechanisms of cancer induction by tobacco-specific NNK and NNN. Cancers 2014;6:1138-56. Doi: 10.3390/cancers 6021138.

Cibula D, Gompel A, Mueck AO, et al. Hormonal contraception and risk of cancer. Hum Reprod Update 2010;16:631-51.


  • There are currently no refbacks.

Copyright (c) 2017 Universa Medicina

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Creative Commons License
Universa Medicina by Faculty of Medicine, Trisakti University is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Based on a work at